Robert A. Wolff

机构：The University of Texas MD Anderson Cancer Center, Kleijnen Systematic Reviews (United Kingdom) · ORCID：0000-0002-6614-1610

发表论文 1033 篇 · 总被引 47137 次 · h-index 105

代表论文

• Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer (2025 · Cancer Cell · 被引 26)
• A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 5)
• Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer (2026 · The Oncologist · 被引 4)
• Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma (2026 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Pegfilgrastim (Neulasta)-induced acute aortitis: a case report (2025 · European Heart Journal - Case Reports · 被引 3)
• Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients (2026 · Journal for ImmunoTherapy of Cancer)